menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Population Health' ×
A new QuintilesIMS Institute report explores the steady growth of drug expenditure in five developed countries, and what is driving these trends.
Read More
John Procter
Medical science liaisons provide a bridge between drug development and external stakeholders, meaning they are in an ideal situation to capture valuable scientific insights.
Read More
Ray Huml
With patent expirations looming, biologic companies must innovate – or litigate – to protect their market share.
Read More
Olga Uspenskaya-Cadoz
Tau imaging and predictive analytics take center stage at the annual event held by the Alzheimer’s Association.
Read More
Deep Patel
The growing need to treat and prevent AD is spurring new research, but healthcare industry stakeholders need to work collaboratively if we are going to successfully bring groundbreaking treatments to market.
Read More
Alison Bourke
QuintilesIMS Research Forum showcases groundbreaking studies using RWD that are aiding public policy decisions and treatment protocols.
Read More
Ray Huml
Joan Drucker
How the industry is collaborating to rapidly develop better diagnostics and innovative vaccines in response to this global healthcare crisis.
Read More
John Doyle
Expectations for RWE are shaping the value conversation in healthcare. At this year’s ISPOR, we will explore what this trend means for pharma and how they can generate the most benefit from these studies.
Read More
NancyDreyer
How pragmatic clinical trials (PCTs) increase the robustness of real world studies at a fraction of the cost of classical randomized controlled clinical trials (RCTs).
Read More